Thomas Wellner appointed CEO of CML Healthcare

Former president and general manager of Lilly Germany Thomas Wellner has been appointed CEO of CML Healthcare.

Wellner takes over from company chair Patrice Merrin, who had been interim CEO of the Canada-based provider of laboratory testing services since May, 2011.

"We are very pleased to welcome Tom Wellner to CML,” said Merrin. “During the course of his career, Tom has had exposure to numerous healthcare and payor systems as well as to the critical interface of diagnostics, physicians, patients and treatment regimens.”

Prior to his new appointment, Wellner was president and CEO of Canadian biopharma Therapure Biopharma, from 2008 to 2011.

Before his time at Theapure he spent a total of 20 years at Eli Lilly & Company holding senior roles in China, the US, the UK and Latin America.

These included executive director marketing and sales, European Operations at Eli Lilly and Company and director marketing at Eli Lilly Canada, as well as his position in Germany.